Brand Strategy
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize...
Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development
The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients
New Webinar: 2026 Engagement Strategies For Modern Pharma
Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!
NEW Pharma-exclusive Webinar: From Fragmented to Flawless, A Blueprint for Unified Omnichannel in Pharma
Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar on Oct 28 & 29 to get the blueprint for a truly unified and...
Eli Lilly to expand long-standing Purdue University partnership with $250m investment
The alliance will aim to bring medicines to patients faster using advanced technologies
AstraZeneca announces $2.5bn investment in China to boost R&D capabilities
The funds will go towards a new global research and development centre in Beijing’s BioPark
Chiesi Group invests €400m to establish biotech centre of excellence in Italy
The facility is dedicated to developing and producing monoclonal antibodies, enzymes and other proteins
Eli Lilly announces new $4.5bn US site for manufacturing and drug development
The Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers
Answering some of Pharma’s big questions to drive brand strategies
By James Aird and Zoë van Helmond
FDA establishes rare disease innovation hub to accelerate treatment development
More than 30 million people in the US are currently affected by a rare disease
Experts issue call for new ‘toolbox’ to simplify early-phase clinical trial regulation in UK
The article outlines several recommendations to help improve early-phase clinical trials
Sanofi, Formation Bio and OpenAI announce AI collaboration to accelerate drug development
The companies will combine data, software and tuned models to bring new medicines to patients more efficiently